Cornelius et al., 2008 - Google Patents
Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plagueCornelius et al., 2008
View PDF- Document ID
- 16286078864209217014
- Author
- Cornelius C
- Quenee L
- Overheim K
- Koster F
- Brasel T
- Elli D
- Ciletti N
- Schneewind O
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Vaccine and therapeutic strategies that prevent infections with Yersinia pestis have been sought for over a century. Immunization with live attenuated (nonpigmented) strains and immunization with subunit vaccines containing recombinant low-calcium-response V …
- 230000003053 immunization 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cornelius et al. | Immunization with recombinant V10 protects cynomolgus macaques from lethal pneumonic plague | |
| Brown et al. | The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300 | |
| Falugi et al. | Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus | |
| Oliver et al. | Neisseria lactamica protects against experimental meningococcal infection | |
| Hagan et al. | Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection | |
| Shupp et al. | Identification of a transcytosis epitope on staphylococcal enterotoxins | |
| Wieser et al. | A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice | |
| Priebe et al. | Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant | |
| Mara-Koosham et al. | Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains | |
| Quenee et al. | Yersinia pestis caf1 variants and the limits of plague vaccine protection | |
| Kim et al. | Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs | |
| Reed et al. | Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain | |
| Xu et al. | Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice | |
| Zhang et al. | Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model | |
| Naito et al. | The protective effects of nasal PcrV‐CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia | |
| Mocca et al. | Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of Staphylococcus aureus skin and soft tissue infections | |
| Bhattacharjee et al. | Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine | |
| Sedaghat et al. | Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice | |
| Hamaoka et al. | Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia | |
| Ivanov et al. | Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1− Yersinia pestis | |
| Burnside et al. | Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection | |
| Huang et al. | Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine | |
| Koirala | Plague: disease, management, and recognition of act of terrorism | |
| Fellows et al. | Characterization of a cynomolgus macaque model of pneumonic plague for evaluation of vaccine efficacy | |
| Quenee et al. | Plague in Guinea pigs and its prevention by subunit vaccines |